USPSTF recommends against beta carotene, vitamin E supplements
Jun 21, 2022
No benefit was seen for cardiovascular disease or cancer prevention, and evidence was insufficient for assessing the pros and cons of multivitamins.
U.S. spends more on cancer than other countries, but without mortality benefit
Jun 01, 2022
The United States had the highest per capita spending on cancer care in 2020 but a median cancer mortality rate.
New cancer diagnosis may up risk for cardiovascular death, morbidity
Mar 15, 2022
The highest cardiovascular risk was seen for patients with genitourinary, gastrointestinal, thoracic, nervous system and hematologic malignancies.
Meat intake after diagnosis not tied to colon cancer outcomes
Mar 02, 2022
The postdiagnosis intake of unprocessed red meat or processed meat was not linked with a recurrence or mortality risk in patients with stage III colon cancer.
Muscle strengthening may cut risk for noncommunicable disease
Mar 01, 2022
Muscle-strengthening activities were inversely linked to risks for all-cause mortality and major noncommunicable diseases.
Persistent Black-white disparities seen in cancer mortality
Feb 10, 2022
Mortality rates were 41% higher for breast cancer for Black women, despite similar or lower incidence rates compared with whites.
Overall breast cancer incidence decreased from 1999 to 2018
Jan 13, 2022
Incidence increased from 2004 to 2018 and among non-Hispanic Asian or Pacific Islander women and those aged 20 to 39 years.
Incidence of advanced lung cancer continues to decline in the U.S.
Jan 13, 2022
During 2014 to 2018, the incidence continued to increase slowly for female breast cancer and remained stable for prostate cancer.
Sitting, inactivity increase death risk among cancer survivors
Jan 13, 2022
The risk for both all-cause and cancer-specific death increased for cancer survivors with a combination of prolonged sitting and inactivity.
Cancer patients with breakthrough COVID-19 remain at risk for severe outcomes
Dec 27, 2021
No significant difference was observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19.